Whittier Trust’s 10x Genomics TXG Stock Holding History

Whittier Trust’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-400	Closed	-$8.76K	–	1409
2026 Q1	$8.76K	Buy	+400	New	+$8K	﹤0.01%	1144
2025 Q4	–	Sell	-25	Closed	-$319	–	1427
2025 Q3	$319	Hold	25	–	–	﹤0.01%	1362
2025 Q2	$289	Sell	25 -4,650	-99%	-$42.4K	﹤0.01%	1486
2025 Q1	$40.8K	Buy	+4,675	New	+$58.9K	﹤0.01%	969

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Whittier Trust's TXG Position: Q2 2026 in Review

Whittier Trust sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 400 shares — an estimated $8.76K sold.

Whittier Trust first reported a position in TXG in Q1 2025 and held it in 4 quarters. The position peaked at $40.8K in Q1 2025. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Whittier Trust reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
Whittier Trust sold 400 10x Genomics shares in Q2 2026, an estimated $8.76K.
Whittier Trust first reported a position in 10x Genomics in Q1 2025 and held it in 4 quarters.
Whittier Trust's 10x Genomics position peaked at $40.8K in Q1 2025.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.